However, ATRA-treatment of APL cells boosts C/EBPβ expression very strongly [46], raising the possibility that the high concentration of C/EBPβ in ATRA-treated cells leads to a transcriptional output that overrides its pro-leukemic function at lower concentrations of C/EBPβ. This evidence concerns the gene CEBPB and acute promyelocytic leukemia.